Abstract
Background
There is limited literature in children on efficacy of different routes of vitamin B12 administration for vitamin B12 deficiency macrocytic-megaloblastic anemia.
Objective
To compare parenteral with oral vitamin B12 therapy in children with macrocytic-megaloblastic anemia.
Study design
Single-center, open-label randomized controlled trial.
Participant
80 children aged 2 month-18 year with clinical and laboratory features of nutritional macrocytic anemia.
Intervention
All children received an initial single parenteral dose of 1000 µg vitamin B12 followed by randomization to either parenteral or oral vitamin B12 for subsequent doses. Group A was given 1000 µg intramuscular (IM) vitamin B12 (3 doses on alternate days for those aged <10 year, five doses for age >10 year), followed by monthly 1000 µg IM for the subsequent two doses. Group B was given daily oral vitamin B12 1500 µg (500 µg in <2 years age) for three months. Folic acid and iron supplementation, and relevant dietary advice were given to both groups in a similar fashion.
Outcome
Improvement in serum vitamin B12 levels and total hemoglobin was compared three months post-treatment.
Result
The median(IQR) increase in serum vitamin B12 level was significantly higher in group A [600 (389,775) vs 399 (313, 606) pg/mL; P= 0.016]. The median (IQR) rise of hemoglobin was also more in group A [2.7 (0.4,4.6) vs 0.5 (-0.1,1.2) g/dL; P=0.001].
Conclusion
Increase in serum vitamin B12 levels and hemoglobin was better in children with nutritional macrocytic anemia receiving parenteral as compared to oral vitamin B12.
Similar content being viewed by others
References
Sarna A, Porwal A, Ramesh S, et al. Characterisation of the types of anemia prevalent among children and adolescents aged 1–19 years in India: a population-based study. Lancet Child Adolesc Health. 2020;4:515–25.
Nutritional Anemias in infancy and childhood. In: Parthasarthy A. IAP Textbook of Pediatrics, 5th Edition. Jaypee Brothers Medical Publishers. 2013.p. 653–54.
Sinclair L. Recognizing, treating, and understanding pernicious anemia. JRSM Open 2008;101:262–4.
Oh RC, Brown DL. Vitamin B12 deficiency. Am Fam Physician. 2003;67:979–86.
Butler CC, Vidal-Alaball J, Cannings-John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: A systematic review of randomized controlled trials. Family Pract. 2006;23:279–85.
Vidal Alaball J, Butler C, Cannings John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005;3:CD004655.
Kuzminski AM, Del Giacco EJ, Allen RH, et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998;92:1191–98.
Takahashi N, Kameoka J, Takahashi N, et al. Causes of macrocytic anemia among 628 patients: mean corpuscular volumes of 114 and 130 fL as critical markers for categorization. Int J Hematol. 2016;104:344–57.
Babior BM, Bunn HF. Megaloblastic anemias. In: Dennis L Kasper DL, Harrison TR. Harrison’s Principles of Internal Medicine, 16th ed. McGraw-Hill, Medical Pub. Division, 2005.p.601–2.
Ulak M, Chandyo RK, Adhikari RK, et al. Cobalamin and folate status in 6 to 35 months old children presenting with acute diarrhea in Bhaktapur, Nepal. PLoS One. 2014; 9:e90079.
Langan RC, Goodbred AJ. Vitamin B12 deficiency: recognition and management. Am Fam Physician. 2017;96:384–9.
Wang H, Li L, Qin LL, et al. Oral vitamin B 12 versus intramuscular vitamin B 12 for vitamin B 12 deficiency. Cochrane Database Syst Rev. 2018;3:CD004655.
Bolaman Z, Kadikoylu G, Yukselen V, et al. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: A single-center, prospective, randomized, open-label study. Clin Ther. 2003;25:3124–34.
Nyholm E, Turpin P, Swain D, et al. Oral vitamin B12 can change our practice. Postgrad Med J. 2003;79:218–9.
Verma D, Chandra J, Kumar P, et al. Efficacy of oral methylcobalamin in treatment of vitamin B12 deficiency anemia in children. Pediatr Blood Cancer. 2017;64:e26698.
Bahadir A, Reis PG, Erduran E. Oral vitamin B 12 treatment is effective for children with nutritional vitamin B 12 deficiency. J Paediatr Child Health. 2014;50:721–5.
Sezer RG, Akoðlu HA, Bozaykut A, et al. Comparison of the efficacy of parenteral and oral treatment for nutritional vitamin B12 deficiency in children. Hematology. 2018; 23:653–7.
Kolber MR, Houle SK. Oral vitamin B12: A cost-effective alternative. Can Fam Physician. 2014;60:111–2.
Vidal-Alaball J, Butler CC, Potter CC. Comparing costs of intramuscular and oral vitamin B12 administration in primary care: A cost-minimization analysis. Eur J Gen Pract. 2006;12:169–73.
Funding
Funding: None
Author information
Authors and Affiliations
Contributions
Contributors: RT, JT,: literature search, Interpretation of data, drafting the article, revising it critically for important intellectual content; UP, KT: concept and design of study, acquisition of data, analysis and interpretation of data, drafting and revising it critically for important intellectual content and final approval of the version; MP: re-analyzing data and interpretation of data, revising it critically for important intellectual content. All authors approved the final version of manuscript, and are accountable for all aspects related to the study.
Corresponding author
Ethics declarations
Ethics clearance: IEC, Pramukhswami Medical College; No. HREC/HMPCMCE/2015/129, dated March 14, 2015.
Competing interests: None stated.
Additional information
Note: Additional material related to this study is available with the online version at https://www.indianpediatrics.net
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Tandon, R., Thacker, J., Pandya, U. et al. Parenteral vs Oral Vitamin B12 in Children With Nutritional Macrocytic Anemia: A Randomized Controlled Trial. Indian Pediatr 59, 683–687 (2022). https://doi.org/10.1007/s13312-022-2594-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-022-2594-2